BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 25868876)

  • 1. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
    Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
    EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
    Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
    EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
    Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
    Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
    EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An embolic deflection device for aortic valve interventions.
    Nietlispach F; Wijesinghe N; Gurvitch R; Tay E; Carpenter JP; Burns C; Wood DA; Webb JG
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1133-8. PubMed ID: 21087748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications for diffusion-weighted MRI brain lesions associated with transcatheter aortic valve replacement.
    Meller SM; Baumbach A; Brickman AM; Lansky AJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):502-8. PubMed ID: 23460315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
    Mylotte D; Sudre A; Teiger E; Obadia JF; Lee M; Spence M; Khamis H; Al Nooryani A; Delhaye C; Amr G; Koussa M; Debry N; Piazza N; Modine T
    JACC Cardiovasc Interv; 2016 Mar; 9(5):472-80. PubMed ID: 26965937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.
    Abdul-Jawad Altisent O; Ferreira-Gonzalez I; Marsal JR; Ribera A; Auger C; Ortega G; Cascant P; Urena M; Del Blanco BG; Serra V; Sureda C; Igual A; Rovira A; González-Alujas MT; Gonzalez A; Puri R; Cuellar H; Tornos P; Rodés-Cabau J; Garcia-Dorado D
    Clin Res Cardiol; 2016 Jun; 105(6):508-17. PubMed ID: 26646556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
    Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
    J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral events and protection during transcatheter aortic valve replacement.
    Freeman M; Barbanti M; Wood DA; Ye J; Webb JG
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):885-96. PubMed ID: 24550141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty.
    Bijuklic K; Haselbach T; Witt J; Krause K; Hansen L; Gehrckens R; Rieß FC; Schofer J
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1608-13. PubMed ID: 26386760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.
    Manoharan G; Walton AS; Brecker SJ; Pasupati S; Blackman DJ; Qiao H; Meredith IT
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1359-1367. PubMed ID: 26315740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.